September 20, 2013 7:48 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at Goldman Sachs initiated coverage on shares of Verisk Analytics (NASDAQ: VRSK) with a “neutral” rating. The target price for Verisk Analytics is set to $68. Verisk Analytics' shares closed at $66.39 yesterday. JP Morgan initiated coverage on shares of NPS Pharmaceuticals (NASDAQ: NPSP) with an “overweight” rating. The target price for NPS Pharmaceuticals is set to $40. NPS Pharmaceuticals' shares closed at $29.01 yesterday.Credit Suisse initiated coverage on shares of Macerich Company (The) (NYSE: MAC) with an “underperform” rating. The target price for Macerich Company is set to $58. Macerich's stock closed at $59.61 yesterday.Analysts at Citigroup initiated coverage on shares of Clovis Oncology (NASDAQ: CLVS) with a “buy” rating. The target price for Clovis Oncology is set to $109. Clovis Oncology's shares closed at $75.23 yesterday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.